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Synthesis of Aspernigrin A
Abstract
Aspernigrin A is a compound correlated with inhibiting the growth of cancer cells 
in the colon. A five-step synthesis was designed for aspernigrin A, projected to yield four 
intermediates and the final product. The intermediates were analyzed by high field 1H- 
NMR and FT-IR spectroscopy before proceeding to the next step. A model pyridone ring 
system was successfully prepared from a commercially available pyrone precursor in two 
steps. These results provide a proof of concept that the synthetic scheme should 
successfully yield the natural product.
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Introduction
Cladosporium herbarum, IFB-E002 (isolate) is an endophytic fungus that lives in 
the leaves of Cynodon dactylon (crabgrass). Aspernigrin A, a biologically active 
metabolite, has been isolated from this fungus by Ye, et al1. This compound may inhibit 
the growth of line SW1116 of colon cancer cells1. Aspernigrin A (1, 4-benzyl-6-oxo-l,6- 
dihydropyridine-3-carboxamide, figure 1) has also been isolated by Hiort, et al from 
Aspergillus niger, which is a common fungus from the Mediterranean sea sponge, 
Axinella damicornis .
Aspergillus niger is a very common fungus; it is all around us. Right now we are 
breathing it in and out with no detrimental effects on our biological systems. Fungi have 
particularly interesting symbiotic relationships with their hosts. Generally, the 
relationship is mutually beneficial between the host and fungi3. This means that the 
fungus is provided a house to live in, while it gives the host some protection from 
predation4. To help protect their hosts from being eaten, many fungi excrete secondary 
metabolites. Aspernigrin A is a metabolite characterized as an alkaloid due to the fact that 
it contains nitrogen. Alkaloids often have an adverse effect on animals that would ingest 
them5.
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Aspernigrin B (2, figure 1) was also isolated from Aspergillus niger, the sea 
sponge symboint, and if the synthesis of aspernigim A is successful, it may provide an 
important lead into methodology for the synthesis of aspernigrin B because of the 
structural similarities between the two compounds. Aspernigrin B is linked with 
protecting neuronal cell death caused by glutamic acid2. Thus aspernigrin B could be a 
lead compound for treatments for central nervous system diseases such as Alzheimer’s.
The observed biological activity shows these two compounds have the ability to 
react with receptors in the colon and brain that are possibly linked with color cancer and 
Alzheimer’s disease, respectively. One receptor linked very closely with Alzheimer’s 
disease is the NMDA (A-methyl D-aspartate) receptor6. This receptor is activated by 
elevated glutamic acid. Some glutamic acid is necessary in the brain because of its 
importance in synaptic plasticity or the ability of the connection between two neurons to 
change in strength, which is necessary in memory and learning. Elevated levels of 
glutamic acid can damage the cell membranes and trigger the mitochondria to break 
down, which releases apoptotic factors into the cell, which will eventually kill the cells. 
This neuronal death leads to damage in the frontal lobe.7
Due to its simpler structure, which lacks a stereocenter, we sought to synthesize 
aspernigrin A in a laboratory setting. Chemical synthesis of aspernigrin A is important 
because sea sponges are being harvested extensively and thus are becoming more scarce 
in the environment. Synthesis would prevent the over harvesting of sea sponges which 
would be necessary for isolation of this metabolite. Also, in the laboratory, more 
experiments can be performed to synthesize structural analogs, which may have increased 
bioactivity when compared to the bioactivity of aspernigrin A.
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Achievement of this synthesis would allow for possible modifications to the 
laboratory synthesis making it more timely and effective by finding quicker ways to 
complete parts of the reaction or increase the yield. Cutting down the synthesis time 
would make it less costly and easier to reproduce. This could stimulate interest in 
synthesis and testing by pharmaceutical companies or cancer researchers. This could also 
lead researchers to delve deeper into the benefits of aspernigrin B and its synthesis due to 
the structural similarities between aspernigrin A and aspernigrin B.
Pharmaceutical companies may be interested in the aspernigrins if the compounds 
can be synthesized successfully and if they can be definitively linked to biological 
activity against cancer or Alzheimer’s disease. Ultimately, a new drug could be 
developed for the treatment of cancer or Alzheimer’s disease. If other diseases are 
associated with an excess of glutamic acid in the brain, treatment options may also be 
opened up for other central nervous system diseases.
Results and Discussion
/------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
This arrow means "yields." A single reaction step is required to convert
---------*■ the compound on the left side of the arrow (the starting material) to the
compound on the right side of the arrow (the product.)
--------► This arrow also means "yields," but more than one reaction step is required
*■ to convert the starting material into the product.
This arrow means "can be made from." The compound on the left side of the arrow 
I-. — > can be made from the compound on the right side in an unspecified number of steps.
This type of arrow is called a retrosynthetic arrow and implies thinking backwards from 
a desired target to a simpler precursor.
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Scheme 2. Model reactions for constructing the pyridone ring system.
Based on the examination of the literature,8 we developed a retrosynthetic 
scheme, as seen in Scheme 1. The precursor of the pyridone ring of (1) is a pyrone (3), 
which can be obtained from the thermal cyclization of a diketoester (4) precursor. We 
then faced two challenges; the first was to make sure that the chemistry to convert the 
pyrone to the pyridone was possible. To develop the required reaction conditions, we 
chose to use commercially available 6-methylpyrone (6, scheme 2) as our model 
compound. Second, we had to construct the desired diketoester.9 There are several ways 
to do this, however the main problem with this reaction stems from pKa issues relating to 
the a-H, which could result in very low percent yields, as described further below.
(6) (10) (11) (12) (5)
Scheme 3. Pyrone to pyridone reaction sequence.
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Scheme 1. Retrosynthetic analysis of aspernigrin A (1).
(5) (6)
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The focus of my research project was the pyrone/pyridone model chemistry,
shown in Scheme 3. The literature reference (Kilboum & Seidel)8 that was used as the 
basis for this chemistry was over 30 years old and complete data was not reported for all 
compounds. There have been many changes and advancements in technology since the 
1970s. Because of this, it was necessary to perform a complete analysis of each 
intermediate. Not only was the reaction progress checked using TLC and purity assessed 
by melting point, but also FT-IR and FT-NMR data were used to confirm that the 
products had indeed been synthesized.
The addition reaction of dimethylformamide dimethylacetal (10) to 6- 
methylpyrone (6) in dioxane proceeded in 50% recrystallized yield. The melting point of 
(11) which was 146°C was close to the literature range of 152-154°C.8 value and all 
spectroscopic data corresponded to the expected values. Once it was determined that (11) 
had indeed been formed, we could use the product of subsequent identical reactions after 
only TLC, melting point, and NMR analysis.
The second step required some method development. The literature reference 
called for ammonia gas to be bubbled through the reaction to isomerize pyrone (11) to 
pyridone (12).8 For cost and safety reasons, however, we wanted to use methanolic 
ammonia. At first, we speculated that the reaction did not go to completion and an 
intermediate (3-(aminomethylene)-4-oxo-6-methyl-2-pyrone) (13) which according to
Kilboum & Seidel, was formed along with the desired product (12).8 Because of this, we 
added 2-propanol to cause precipitation. Although the melting point of our product was 
higher than that reported for compound 13, we needed conclusive data that would help us 
assign the structure to differentiate between the two.
7
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Figure 2. Compounds 12 and 13 represent the possible products of the pyridone 
isomerization reaction.
High field one- and two-dimensional NMR data was used to conclusively
determine the structure of the intermediate because low-field one-dimensional NMR data
were inconclusive. High field one-dimensional 1H-NMR yielded the expected methyl and
the two sp2 hydrogen peaks; however, this provided no help in distinguishing between the
two intermediates. The one-dimensional 13C spectra showed the expected seven carbons
8at the appropriate chemical shifts as according to the literature.
While this lead us to believe that we had actually made compound 12 (figure 2), 
we still needed to prove the absolute structure of the product based on chemical shift and 
correlations. To do this we used the nuclear 
Overhauser effect (NOE). NOE difference 
spectroscopy shows correlations through space as 
opposed to the traditional bond correlations. For the 
NOE experiment, (Figure 3, appendix) we chose a 
peak that we could assign unambiguously (methyl, 2.3 ppm) and irradiated it. As a result 
of the irradiation, a peak representing any hydrogen less than 4A away will appear as a 
positive (normal) peak after subtraction of the normal spectrum. Therefore, the peak that 
showed up in the positive direction is the peak representing the hydrogen that is next to 
the methyl group in space. In this case, the peak with a chemical shift of 6.5 ppm was the 
positive peak. Therefore, the H at 6.5 ppm is assigned to be the H next to the methyl
Figure 4. NMR #2 (NOE)
8
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group. Spartan'02 data corroborates this conclusion with a calculated distance of 2.4A. 
This relationship, shown by Figure 4, also assigns the peak at δ=8.5 to the hydrogen next 
to the amine by default.
We also looked at an HSQC (heteronuclear single quantum correlation) spectrum. 
This spectrum correlates directly bound carbons and hydrogens (correlations through one
bond). From this, we can figure out which 
hydrogen is directly connected to which carbon 
(Figure 5, appendix). We concluded that the H 
at 6.5 ppm (red) was directly correlated to the 
carbon at 117 ppm and the H at 8.5 ppmFigure 6. NMR #10 (HSQC) carbon a( j ]7 ppm and the H at g 5 ppm
(green) was directly correlated to the carbon peak at 143 ppm. This left the last 
correlation of the methyl group at 2.3 ppm (blue) correlated with the carbon peak at 19.1 
ppm.
(a ) (b) (c) (d)
Figure 8. HMBC Correlations. Letters a-c represent correlations suggesting that 
compound 12 was the product and letter d shows why the product cannot be 
compound 13.
These correlations, however, do not positively differentiate desired compound 12 
from 13. To do this we used an HMBC (heteronuclear multiple bond coherence). These 
spectra identify long range H-C correlations; that is, hydrogen to carbons two and three 
bonds away. The one-bond H-C correlations of the HSQC are not seen on this spectrum
6.5 ppm
8.5 ppm
6.5 ppm
8.5 ppm impossible 
5-bond correlation
8.5 ppm
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Carbon ppm
2 142
3 118
4 178
5 119
6 151
14 166
(3) (7) (8) (9)
Scheme 4. Retrosynthetic analysis of diketoester (7).
Now that we were confident that the isomerization reaction had been 
accomplished, a total synthesis of aspernigrin A (1) required benzylpyrone (3) as the 
precursor, as shown in Scheme 4, above. In the literature9 the thermal cyclization of 
diketoesters and their equivalents has been used to yield pyrones. Thus, diketoester (7) 
was required. This synthesis, performed by Stephen Waters, was the second challenge we 
faced. To obtain (7), we should be able to acylate a dianion of ethyl acetoacetate (9, 
Scheme 5, below) with an ester or acid chloride of phenylacetatic acid. Because ethyl
10
Table 1. NMR literature 
chemical shift data supporting 
the assignment of compound 
12 as the product.1
(Figure 7, appendix). This allowed us to make the remaining carbon assignments, with 
the exception of the
carbonyls. These data eliminate the possibility of 
compound 13 being our product because the hydrogen at 
8.5 ppm correlates to the carbon at 152 ppm. In compound 
12, this carbon is three bonds away to the carbon at 152 
ppm (Figure 8, c); however, in compound 13 it is five 
bonds away (Figure 8, d). This five-bond correlation 
would not show up on the HMBC. Also, when we
compared our carbon assignments made using the 
spectral data to the literature values for aspernigrin A, our 
chemical shifts are nearly identical as seen in Table l .1
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phenylacetate (8) was readily available, we proceeded in this manner. This reaction was 
done three times, but no product was obtained until the last trial due to pKa issues with 
the α-hydrogen because it is unlikely that the reaction would proceed the way desired 
based n the pKa of the a-hydrogen. We tried to overcome this issue with very slow drop 
wise addition of the ethyl phenylacetate at -78°C; a very small amount of product (7) was 
isolated after column chromatography. High field NMR showed what we speculated to be 
a mixture of at least two enol tautomers. There are four possible enols of the diketo 
functionality and we were unable to determine the identity of our mixture from the NMR 
data. Molecular modeling using Spartan was used to determine which enol(s) were 
thermodynamically most stable. Because the heats of formation of the enols were within 
1 kcal/mol of each other, we were again unable to see a significant difference.
Scheme 5. Synthesis of diketoester (7).
If more time for the project was allotted, further research would be to convert the 
carboxylic acid (12) made in the model reaction sequence to the amide (5) using thionyl 
chloride and ammonia. More research might also be done to optimize the isomerization 
with methanolic ammonia to improve the rate and chemical yield of the reaction. 
Additionally, the methyl pyridone (5) is a structural analog of aspernigrin A (1). A 
bioassay could also be developed to look into the bioactivity of aspernigrin A as well as
11
(4) (3)
Aspernigrin A (1)
(9)
( 8 )
(4)
1. LDA, TMEDA
2 .
and
Δ
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some of its structural analogs. It would also be beneficial to try using the synthetic 
aspernigrin A as a starting point to try to synthesize aspernigrin B.
Materials and Methods
General Methods. Melting points were obtained on a Mel-Temp II apparatus 
and are uncorrected. Thin layer chromatography employed aluminum backed Merck 
Silica Gel 60 plates with fluorescent indicator, which were cut to size. Infrared spectra 
were acquired on a ThermoNicolet Avatar 360 Fourier-transform infrared spectrometer 
using KBr pellets. Low field NMR spectra were obtained with an Anasazi Instmments, 
Inc., Eft-60 spectrometer interfaced to a Hitachi Perkin-Elmer R24B permanent magnet. 
High field 1H-, 13C-, and two-dimensional NMR spectra were recorded on a JEOL ECX 
400 spectrometer operating at 400 MHz for 1H and 100 MHz for 13C. Molecular 
modeling was conducted using Spartan’02, Wavefunction, Inc. Commercially available 
compounds and reagents were obtained from Aldrich Chemical Company.
3-(Dimethylaminomethylene)-4-oxo-6-methyl-2-pyrone (11). 4-Hydroxy-6- 
methyl-2-pyrone (6) (1.0049g, 7.98 mmol, 3.87% equiv.) was combined with 1.73 grams 
(14.8 mmol, 3.93% equiv) N,N-dimethylformamide dimethyl acetal (10) in 4 mL of p- 
dioxane and stirred until a brownish/red color appeared. Reaction progress was checked 
with thin layer chromatography (TLC) (5% methanol in chloroform). The reaction was 
capped and stored at 4°C overnight. 2-Propanol was added with stirring. The resulting 
solid was collected by vacuum filtration and crystallized from 2-propanol, yielding 
0.6037 g, 50%, mp 146°C (literature8 mp 152-154°C). 1H-NMR (DMSO-d6) δ = 2.17 (s,
12
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3 H, C-methyl), 3.27 (s, 3 H, N-methyl), 3.52 (s, 3 H, N-methyl), 5.67 (s, 1 H, olefinic) 
and 8.32 (s, 1 H, olefinic) (Figure 9, appendix).
6-Methyl-4-(lH)-pyridone-3-carboxylic acid (12). 3- 
(Dimethylaminomethylene)-4-oxo-6-methyl-2-pyrone (11) (0.1205 g, 0.666 mmol, 
0.463% equiv.) was combined with 1 mL of 2-methoxyethanol and 1 mL of 7 N 
methanolic ammonia in a 25 mL round bottom flask to form. The flask was capped and 
heated to a constant 47° C using a Thermowell® and sand bath. The resulting solution 
turned from colorless to red indicating progress in the reaction. Thin layer 
chromatography (5% methanol: chloroform) was run on the product and reactants. The 
sample was then rotovapped until only an oily residue remained and dissolved in 50 mL 
deionized water. The product was then acidified with 30 mL of glacial acetic acid, 
however no suspension formed. The sample was sealed and stored at 4°C overnight.
The sample was removed from the refrigerator and once it reached room 
temperature, toluene (20 mL) was added to lower the boiling point of the acetic acid and 
evaporated under low pressure. TLC (5% methanol in chloroform) was run and 
bromocresol green and ninhydrin stains were used. Bromocresol green was used to 
identify the presence of the carboxylic acid and the ninhydrin stain indicated the presence 
of an amine in the product. 2-Propanol was added and the sample was sealed and placed 
in an ice bath to encourage precipitation. The resulting solid was collected via vacuum 
filtration, collected and stored at 4°C. The filtrate was evaporated under low pressure, the 
oily residue that remained was sealed and stored at 4°C, yielding 0.0926g, 24%. Thin 
Layer Chromatography (5% methanol in chloroform) was run on both products, and the 
plates were stained with ninhydrin. Mp >225°C, IR (KBr) 3200 cm-1 (amine) (Figure 10,
13
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appendix). 1H-NMR (DMSO-d6) δ = 8.459 (C-H), 6.558 (C-H), 2.324 (methyl); NOE 
(irradiated methyl) δ=6.5; HSQC δ = 6.5 (117), 8.5 (143), 2.3 (19.1); HMBC: Carbon 
(δ) = 2 (143), 3 (114), 4 (179), 5 (119), 6 (152), 14 (167) (Figure 11, appendix).
Acknowledgements
I would like to thank Dr. Anne Reeve for her all of her help and expertise on this 
project and for being my committee chair. I would like to thank Steve Waters for taking 
on this project with me and attempting the synthesis of the other half of the compound. I 
would also like to thank my other two committee members, Dr. Priscilla Gannicott and 
Dr. Nancy Cowden. Thank you to Dr. John Beck, Sweet Briar College for use of their 
high-field NMR and to Lynchburg College’s School of sciences for supplies. Also thank 
you to all others who supported me through this endeavor.
14
Synthesis o f Aspernigrin A
References
(1) Ye, H.Y.; Zhu, H.L.; Song, Y.C.; Liu, J.Y.; Tan, R.X. “Structural Revision of 
Aspernigrin A, Reisolated from Cladosporium herbarum IFB-E002,” J. Nat.
Prod. 2005, 68, 1106-1108.
(2) Hiort, J.; Maksimenka, K.; Reichert, M.; Perovic-Ottsadt, S.; Lin, W.H.; Wray,
V.; Steube, K.; Schaumann, K.; Weber, H.; Proksch, P.; Ebel, R.; Muller, W.E.G.; 
Bringmann, G. “New Natural Products from the Sponge-Derived Fungus 
Aspergillus niger”  J. Nat Prod. 2004, 67, 1532-1543.
(3) Kilboum, E.E.; Seidel, M.C. “Synthesis of N-Alkyl-3-carboxy-4-pyridones,”
J. Org. Chem. 1972, 37, 8, 1145-1148.
(4) Acamovic, T., Brooker, J. “Biochemistry of plant secondary metabolites and their 
effects in animals,” Proceedings o f the Nutrition Society, 2005, 64, 3, pp 403-412.
(5) Clay, K. “Symbiosis and the Regulation of Communities,” American 
Zoologist. 2001 41, 4, 2001 pp 810-824.
(6) Cooke, R. The Biology o f Symbiotic Fungi. 1977, John Wiley & Sons, New York.
(7) Hamdy, R., Turnbull, J., Edwards, J., Lancaster, M. Alzheimer’s Disease: A 
Handbook for Caregivers. 1998, Mosby-Year Book Inc, St. Louis, pp 188-189.
(8) Logner, D., Muir, J., Choi, D. “Oxygen-Glucose Deprivation in Neuronal Cell 
Culture,” Cerebrovascular Disease: Pathophysiology, Diagnosis, and 
Management. 1998, (Vol. 1) Ginsberg MD. & Bogousslavsky, pp. 129-136.
(9) Hua, D., Chen,T., Sin, H., Maroto, M., Robinson, P., Newell, S., Perchellet, E., 
Ladesich, J., Freeman, J., Perchellet, J., Chiang, P. “A One-Pot Condensation of 
Pyrones and Enals. Synthesis of 1H, 7H-5a, 6, 8, 9-Tetrahydro-1-oxopyrano [4,3- 
b][1]benzopyrans.” J. Org. Chem. 1997, 62 (20), pp. 6888-6896.
15
Figure 3 NOE difference spectra for 12
16
F r o m : 04/13/2006 13:32 #004 P.010
17
18 F r o m :
04/13/2006 13:31 #004 P.007
jq
tu
q »
ro
pjj
c£
ti t
-o
B
PEAKLIST
LINE POINT HZ PPM I N TENSITY REL INT LABEL
1 2764 494 17 8 232 5264 17 878 1
2 4054 336 77 5 610 7287 24 749 2
3 4770 249 30 4 153 2087 7 088 3
4 5099 209 09 3 483 26041 88 445 4
5 5217 194 70 3 243 24567 83 438 5
6 5802 123 27 2 053 25804 87 639 6
product 1 USER. - D A T E: 01/30/06 ('15:16')
F 1. 60.030 SW1. 1000 O F 1 . 331.6 P T S 1d: 8192
E X .  z g . p p g PW: 22.7 usec PD: 3.0 sec NA. 1 LB: 0.0 WinNuts Tempfids
20
21
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
Lynchburg C o llege  
W ed  M ar 29  16 :12:19  200 6  
W e d  M ar 29  16:18:21 2 0 0 6
4 0 0 0  3 5 0 0  3 0 0 0  2 5 0 0  2 0 0 0  1500  1000  500
W aven u m b ers  (cm -1)
04/13/2006 13:29 #004 P.001From:
